White Paper:

The CNS Market: 2021 Review & Predictions for 2022

In late 2020, we wrote a two-part series on the “quiet revolution” that’s going on in CNS therapies (access part I here and part II here).  In those papers, we made a few predictions about what might happen during 2021 and how the CNS market was likely to evolve.

In this paper, we look back at those predictions and see how good they were.  We also look ahead and make new predictions for 2022.

  • Hidden
  • This field is for validation purposes and should be left unchanged.